Macrolides for the treatment of reversible obstructive air-ways diseases
CA 2054203 C · Owner: Norris, Alan Anthony · Inventors: Norris, Alan Anthony; Akutsu, Ikuo; Fukuda, Takeshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (I), wherein R1 and R2 together represent two vicinal hydrogen atoms, or form a second bond, between the vicinal carbon atoms to which they are attached; R3 represents H OH, alkoxy or protected hydroxy; R4 represents OH; R5 represents H, alkyl or alkenyl; R6 and R7 independently represent O, (H,OH), (H,protected hydroxy) or (H,alkoxy); X and Y independently represent O (H,OH) or (H,H); n is 1 or 2; or , pharmaceutically acceptable derivatives thereof; are provided for the treatment of reversible obstructive airways disease particularly asthma. Compositions containing such compounds are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 6, 1990 and granted August 21, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 6, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 6, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.